Weight loss drugs may quiet Cancer-Linked inflammation
NCT ID NCT05756764
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 23 times
Summary
This study tracks 30 adults with obesity (BMI over 30, ages 35-60) who take standard weight-loss medication for 6 months. Researchers measure weight loss, changes in inflammatory cells in the blood, and levels of cholesterol and other fats. The goal is to understand how losing weight affects chronic inflammation that may raise cancer risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
LSU Clinical & Translational Research Center (CTRC - - LSUHSC-NO
New Orleans, Louisiana, 70112, United States
-
Ochsner Health System - Biospecimen
New Orleans, Louisiana, 70121, United States
Conditions
Explore the condition pages connected to this study.